Zins Karin, Abraham Dietmar, Sioud Mouldy, Aharinejad Seyedhossein
Laboratory for Cardiovascular Research, Department of Anatomy and Cell Biology, Vienna Medical University, Waehringerstrasse 13, A-1090 Vienna, Austria.
Cancer Res. 2007 Feb 1;67(3):1038-45. doi: 10.1158/0008-5472.CAN-06-2295.
The interplay between malignant and stromal cells is essential in tumorigenesis. We have previously shown that colony-stimulating factor (CSF)-1, matrix metalloprotease (MMP)-2, and vascular endothelial growth factor (VEGF)-A production by stromal cells is enhanced by CSF-1-negative SW620 colon cancer cells. In the present study, the mechanisms by which colon cancer cells up-regulate host factors to promote tumorigenesis were investigated. Profiling of tumor cell cytokine expression in SW620 tumor xenografts in nude mice showed increased human tumor necrosis factor (TNF)-alpha mRNA expression with tumor growth. Incubation of macrophages with small interfering (si) RNAs directed against TNF-alpha or TNF-alpha-depleted SW620 cell conditioned medium versus SW620 cell conditioned medium failed to support mouse macrophage proliferation, migration, and expression of CSF-1, VEGF-A, and MMP-2 mRNAs. Consistent with these results, human TNF-alpha gene silencing decreased mouse macrophage TNF-alpha, CSF-1, MMP-2, and VEGF-A mRNA expression in macrophages cocultured with human cancer cells. In addition, inhibition of human TNF-alpha or mouse CSF-1 expression by siRNA reduced tumor growth in SW620 tumor xenografts in mice. These results suggest that colon cancer cell-derived TNF-alpha stimulates TNF-alpha and CSF-1 production by macrophages, and that CSF-1, in turn, induces macrophage VEGF-A and MMP-2 in an autocrine manner. Thus, interrupting tumor cell-macrophage communication by targeting TNF-alpha may provide an alternative therapeutic approach for the treatment of colon cancer.
恶性细胞与基质细胞之间的相互作用在肿瘤发生过程中至关重要。我们之前已经表明,CSF-1阴性的SW620结肠癌细胞可增强基质细胞产生集落刺激因子(CSF)-1、基质金属蛋白酶(MMP)-2和血管内皮生长因子(VEGF)-A。在本研究中,我们调查了结肠癌细胞上调宿主因子以促进肿瘤发生的机制。对裸鼠SW620肿瘤异种移植瘤中肿瘤细胞细胞因子表达进行分析,结果显示,随着肿瘤生长,人肿瘤坏死因子(TNF)-α mRNA表达增加。用针对TNF-α的小干扰(si)RNA处理巨噬细胞,或将TNF-α缺失的SW620细胞条件培养基与SW620细胞条件培养基进行比较,结果均未能支持小鼠巨噬细胞的增殖、迁移以及CSF-1、VEGF-A和MMP-2 mRNA的表达。与这些结果一致,在与人癌细胞共培养的巨噬细胞中,人TNF-α基因沉默降低了小鼠巨噬细胞TNF-α、CSF-1、MMP-2和VEGF-A mRNA的表达。此外,通过siRNA抑制人TNF-α或小鼠CSF-1的表达可减少小鼠SW620肿瘤异种移植瘤的生长。这些结果表明,结肠癌细胞衍生的TNF-α刺激巨噬细胞产生TNF-α和CSF-1,而CSF-1反过来又以自分泌方式诱导巨噬细胞产生VEGF-A和MMP-2。因此,通过靶向TNF-α中断肿瘤细胞与巨噬细胞之间的通讯可能为结肠癌的治疗提供一种替代治疗方法。